Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1EPRATUZUMAB1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
2Epratuzumab 100 mg1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
3Epratuzumab 1200 mg1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
4Epratuzumab 400 mg1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
5Epratuzumab 600 mg1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
6Epratuzumab iv1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
7Epratuzumab sc1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
8HLL2 (Epratuzumab)1件: Epratuzumab1件: D04036 (Name: Epratuzumab)1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49